|
|
|
|
 Dr Tomoyuki Igawa,
Genome Antibody Product Research Dept Chugai Pharmaceutical Co., Ltd., Japan 1998-2001 Department of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, studying on developing artifical enzymes, awarded master of engineering.
2001-2004 Research scientist at Formulation Technology department, Chugai Pharmaceutical, Co., Ltd., working on formulation of antibody.
2004-2007 Research scientist at Preclinical Research department, Chugai Pharmaceutical, Co., Ltd., working on pharmacokinetic and stability optimization of antibody.
2007-present@Research scientist at Genome Antibody Product Research Department, Chugai Pharmaceutical, Co., Ltd., responsible for antibody engineering, optimization and early CMC development, project leader of antibody therapeutic projects.
Appearing: Conference Day Two: Thursday, 18 March 2010 11.45 Technologies to optimize lead antibody to enable therapeutic development Dr Tomoyuki Igawa, Genome Antibody Product Research Dept,
Chugai Pharmaceutical Co., Ltd., Japan |
|
|
|
|
|
Session sponsor:
Exhibitors:
|
asia research institution poster presentation
* For first 20 confirmed poster presentations
|
|
|
|
|
|
|
|
|
